Neonatal hyperbilirubinemia, which is often linked to UGT1A1 and G6PD variants, is highly prevalent in China, affecting approximately 34.4% of full-term neonates and is generally considered treatable (Yang et al., 2016). This evidence concerns the gene G6PD and Hyperbilirubinemia.